Formulation Development

Robust Database Characterizes And Optimizes Product Development

Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.

SEDDS: Improving Oral Bioavailability Of Poorly Soluble Compounds

Nearly 90% of marketed drugs have poor water solubility. Learn how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.

Extraction And Chemical Characterization Pitfalls In Complex Medical Devices

Standard extraction protocols routinely fail tissue-derived products, hydrogels, absorbables, and silicone implants. Learn the material-specific study design strategies that prevent regulatory rejection and repeat work.

The Bioprocessing Industry Has A Digital Execution Problem

Digital execution remains a major barrier in manufacturing. Learn how fragmented data, manual decisions, and inconsistent adoption affect the ability to bring complex therapies to patients faster.

How Can Biopharma Overcome Digital Transformation Failure?

Biopharma understands the promise of digital transformation, but implementation remains the challenge. Learn why organizational structures must evolve to turn strategies into scalable results.

Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity

Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis.

Differentiate Challenging Site-Specific Isomeric Amino Acids

Learn how high-resolution ion mobility, pre-IMS fragmentation, and product ion analysis can resolve difficult peptide isomers and localize structural differences, supporting confident characterization.

Increase Throughput For Intact Mass Confirmation And Impurity Screening

Accelerate intact mass analysis of GLP-1 analogues with automated purity calculations, sub-ppm mass accuracy, and impurity detection for consistent results in under one minute per sample.

Integrated QC As A Development Strategy: Reducing Late-Stage Analytical Risk

Learn how early QC integration, proactive analytical risk management, and cross-functional collaboration can improve validation readiness, reduce development surprises, strengthen release testing predictability, and help protect critical clinical manufacturing timelines.

Accelerating Phase: Supply Without Sacrificing Discipline

Faster clinical supply delivery starts with the right strategy. Explore how planning, collaboration, communication, and quality systems keep programs on track.